A cost-effective portable device which can measure CD4 cells and has the potential to be used in resource-limited regions has been developed by the Bio-Acoustic MEMS (BAMM) laboratory of Harvard Medical School. Although rapid diagnostic technologies have previously been tested in Bangladesh, quantitative portable monitoring technologies currently do not exist in its healthcare framework. The goal of this project is to evaluate the effectiveness and applicability of this device in Bangladesh.
